| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c303e8e178f0400f047c6c85932b4af8 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-77
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-81
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-324 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-81
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-77
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-324 |
| filingDate |
2008-12-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_39cb75940df261d96d4623a50e741cbe |
| publicationDate |
2010-02-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-2149378-A1 |
| titleOfInvention |
Topical formulations for the symptomatic treatment of musculoskeletal disorders |
| abstract |
Disclosed are topical compositions containing: na) capsaicin or extracts containing them; nb) boswellic acids or Boswellia serrata resin extracts containing them; nc) escin in free form or complexed with beta-sitosterol and/or with phospholipids or Aesculus hippocastanum seed extracts. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/IT-201800006683-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109152747-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020003106-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10960018-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020234770-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/IT-201900007044-A1 |
| priorityDate |
2008-07-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |